Covalon Technologies Ltd Stock Toronto S.E.
Equities
COV
CA22282D3022
Biotechnology & Medical Research
Sales 2022 | 18.15M 13.26M | Sales 2023 | 26.6M 19.44M | Capitalization | 37M 27.05M |
---|---|---|---|---|---|
Net income 2022 | -9M -6.58M | Net income 2023 | -4M -2.92M | EV / Sales 2022 | 2.65 x |
Net cash position 2022 | 13.26M 9.69M | Net cash position 2023 | 7.23M 5.29M | EV / Sales 2023 | 1.12 x |
P/E ratio 2022 |
-6.44
x | P/E ratio 2023 |
-8.33
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.53% |
Latest transcript on Covalon Technologies Ltd
Managers | Title | Age | Since |
---|---|---|---|
Valerio DiTizio
FOU | Founder | - | 04-04-27 |
Amir Boloor
CHM | Chairman | - | 20-04-26 |
Kim Crooks
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Smith
BRD | Director/Board Member | 73 | 19-03-17 |
Abe Schwartz
BRD | Director/Board Member | - | 08-03-06 |
Martin Goldfarb
BRD | Director/Board Member | - | 20-04-22 |
1st Jan change | Capi. | |
---|---|---|
+25.90% | 42.68B | |
-3.90% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.67% | 24.94B | |
-21.62% | 18.96B | |
+27.75% | 12.3B | |
-2.96% | 11.95B | |
-1.88% | 11.55B |